2023
DOI: 10.1080/13543776.2023.2206017
|View full text |Cite
|
Sign up to set email alerts
|

Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 149 publications
0
2
0
Order By: Relevance
“…Trichomonas vaginalis passed from one to another partner during intercourse [53] . For treating these disorders many vaginal formulations such as creams, ointments, powders, and suppositories are used that exhibit shorter residence time and undergo a natural clearance process in the vaginal lumen, irritation, and burning in the vaginal area.…”
Section: Vaginal Pathophysiologymentioning
confidence: 99%
“…Trichomonas vaginalis passed from one to another partner during intercourse [53] . For treating these disorders many vaginal formulations such as creams, ointments, powders, and suppositories are used that exhibit shorter residence time and undergo a natural clearance process in the vaginal lumen, irritation, and burning in the vaginal area.…”
Section: Vaginal Pathophysiologymentioning
confidence: 99%
“…The life cycle of T. gondii has three stages of development including the tachyzoite stage that is characteristic in case of acute infection because of its rapid multiplication, bradyzoite stages that is characteristic in case of chronic infection and its slow multiplication and its existence as muscular or brain tissues cysts, and lastly the sporozoite stage of the definitive hosts (Feline species) which is released in the oocysts with feces deposition (6). Generally, toxoplasmosis is asymptomatic in case of people or animals with potent immune system, or it may induce non-specific or flu-like symptoms (7,8). However, the disease could be manifested with severe symptoms or even fatal in immunocompromised hosts (9).…”
Section: Introductionmentioning
confidence: 99%